WindRose Health Investors’ Recapitalization of Veristat Group – Global Legal Chronicle – Global Legal Chronicle

0
62

McDermott Will & Emery represented WindRose Health Investors in the transaction.

WindRose Health Investors, LLC, a healthcare focused private equity fund, completed its equity recapitalization of Veristat Group Inc. This transaction was completed on March 31, 2021. Financial terms of the transaction were not disclosed.

WindRose partnered with Veristat’s executive team to recapitalize the business and to provide additional capital to support future growth. WindRose’s investment will enable Veristat to accelerate its next phase of expansion, drawing on WindRose’s deep network of relationships and extensive experience investing in healthcare and outsourced pharmaceutical services companies. Veristat’s management will continue to own a significant minority position in the Company going forward.

Veristat is a provider of contract services to pharmaceutical, biotechnology and medical device companies, including biostatistics, biostatistical programming, data management, medical writing, medical device, clinical monitoring, project management, pharmacovigilance and regulatory advisory services to support the submission of marketing applications to the United States Food and Drug Administration, European Medicines Agency and other international regulatory bodies.

WindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. WindRose manages over $1.2 billion in investments and is currently investing out of its fifth fund.

The McDermott team advising WindRose was led by Kristian Werling (Picture) and Jarrett Szczesny and included Nora Klein, Jiayan Chen, Amy Pimentel, Anisa Mohanty, Paul McGrath, Heloise Waudby, Sophie Wood, Rosemary McSwiney, Gary Howes, Todd Harrison, Christopher Whalen, Jeff Holdvogt, Jennifer Mikulina, Ellie Atkins, Dan Doron, Stephania Sanon, Sonia Fulop, Ryan Smethurst, Daphne Trotter, Leigh Ratin, Ty Carson and Greg Heltzer. The McDermott finance team was led by Josh Samis and included Fitsum Tilahun, Caitlin Harrington, Atoosa Nowrouzi and Camila Domingues. The relationship partners for WindRose are Ira Coleman, Krist Werling and Jed Spielman.

Involved fees earner: Eleanor Atkins – McDermott Will & Emery; Timothy Carson – McDermott Will & Emery; Jiayan Chen – McDermott Will & Emery; Ira Coleman – McDermott Will & Emery; Daniel Doron – McDermott Will & Emery; Sonia Fulop – McDermott Will & Emery; Caitlin Harrington – McDermott Will & Emery; Todd Harrison – McDermott Will & Emery; Gregory Heltzer – McDermott Will & Emery; Jeffrey Holdvogt – McDermott Will & Emery; Gary Howes – McDermott Will & Emery; Nora Klein – McDermott Will & Emery; Paul McGrath – McDermott Will & Emery; Rosemary McSwiney – McDermott Will & Emery; Jennifer Mikulina – McDermott Will & Emery; Anisa Mohanty – McDermott Will & Emery; Amy Pimentel – McDermott Will & Emery; Leigh Ratino – McDermott Will & Emery; Joshua Samis – McDermott Will & Emery; Stephania Sanon – McDermott Will & Emery; Ryan Smethurst – McDermott Will & Emery; Joshua Spielman – McDermott Will & Emery; Jarrett Szczesny – McDermott Will & Emery; Fitsum Tilahun – McDermott Will & Emery; Daphne Trotter – McDermott Will & Emery; Heloise Waudby – McDermott Will & Emery; Kristian Werling – McDermott Will & Emery; Christopher Whalen – McDermott Will & Emery; Sophie Wood – McDermott Will & Emery;

Law Firms: McDermott Will & Emery;

Clients: WindRose Health Investors;

LEAVE A REPLY

Please enter your comment!
Please enter your name here